EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Exploring the Therapeutic Effects of Psychedelics Administered to Military Veterans in Naturalistic Retreat Settings

Megan Calnan iD, Grace Blest-Hopley iD, Chris Busch, Milly Adams, Simon G D Ruffell, Theodore Piper, Leor Roseman, Hannes Kettner, Robin Carhart-Harris

Brain and Behavior · 2025-07 · 15 (7)

DOI: 10.1002/brb3.70660 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brain and Behavior, online erschienen am 07.07.2025. Verfasst von Megan Calnan und 8 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Clinical Brain Sciences, Division of Psychiatry, University of Edinburgh, Edinburgh, UK. Hauptthemen laut MEDLINE: Veterans, Hallucinogens, Psilocybin, Stress Disorders, Post-Traumatic. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 89 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Military veterans are at risk of various mental health conditions, with profound implications for post‐deployment quality of life. Current treatment options encounter high dropout rates and non‐responsiveness, and overlook the importance of community building in veterans’ holistic recovery. Preliminary research suggests psychedelics offer therapeutic benefits for depression and post‐traumatic stress disorder (PTSD) in veterans. Integrating psychedelic therapies with a communal retreat setting could provide a more holistic framework for improving veterans’ well‐being.

Objectives

To evaluate the effects of psychedelic retreats on mental health and community reintegration in veterans.

Methods

Fifty‐eight veterans attended psilocybin or ayahuasca retreats. Participants completed eight mental health questionnaires (e.g. PTSD Checklist, PCL‐5; Patient Health Questionnaire, PHQ‐9), and the Military to Civilian Questionnaire (M2C‐Q) up to 4 weeks both pre‐ and post‐retreat. Paired t ‐tests analyzed changes in outcome responses between time points, and gender and substance‐specific analysis was conducted. Baseline scores were correlated with improvements in PCL‐5 and PHQ‐9 to investigate the relationship between initial symptom severity and percentage improvement following the retreat.

Results

Significant improvements were found for all eight outcomes post‐retreat, with the greatest percentage improvements found for depression (PHQ‐9; 29.1%) and PTSD (PCL‐5; 26.1%). Veterans attending psilocybin retreats showed greater improvements in seven out of eight outcomes, whereas ayahuasca retreats demonstrated greater improvements in PCL‐5 scores for PTSD (ayahuasca: 26.4%; Psilocybin 24.8%). Male participants experienced greater improvements across all outcomes apart from the PCL‐5 for PTSD (Male: 24.1%; Female: 32.1%). Higher baseline scores on the PCL‐5 (PTSD) and PHQ‐9 (depression), indicating worse initial mental health, correlated with greater outcome improvements.

Conclusions

This is the first study to investigate psychedelic retreats as a holistic therapy for veterans’ mental health alongside community reintegration. Psilocybin and ayahuasca retreats significantly improved veterans’ mental well‐being, quality of life, PTSD, anxiety, depression, sleep, concussion, and post‐deployment reintegration. Participants with more severe symptoms have the potential to benefit most from this intervention, with nuanced insight into improved outcomes based on gender and type of substance. Psychedelic retreats could provide a treatment framework to aid veterans’ recovery by addressing psychological well‐being, communal factors, and reintegration into civilian life.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

VeteransHallucinogensPsilocybinStress Disorders, Post-TraumaticHumansMaleFemaleAdultMiddle AgedBanisteriopsisDepressionTreatment OutcomeQuality of LifeSurveys and Questionnaires

Stichwörter der Autor:innen

PTSDayahuascamilitarypsilocybinpsychedelicsretreatsveterans

Substanzen

HallucinogensPsilocybin

Autor:innen und Institutionen

  • Centre for Clinical Brain Sciences, Division of Psychiatry, University of Edinburgh, Edinburgh, UK.
  • King's College London, Institute of Psychiatry, Psychology and Neuroscience, London, UK.
  • Health Analytics Collaborative, Maryland, USA.
  • Department of Medicine, Centre for Psychedelic Research, Imperial College London, London, UK.
  • Onaya Science, Iqiuitos, Peru.
  • Social, Therapeutic and Community Studies and the Faiths & Civil Society Unit, Goldsmith, University of London, London, UK.

ORCID-Profile: Megan Calnan, Grace Blest-Hopley

Zitieren

APA

Calnan, M., Blest-Hopley, G., Busch, C., Adams, M., Ruffell, S. G. D., Piper, T., Roseman, L., Kettner, H., & Carhart-Harris, R. (2025). Exploring the Therapeutic Effects of Psychedelics Administered to Military Veterans in Naturalistic Retreat Settings. Brain and Behavior, 15(7). https://doi.org/10.1002/brb3.70660

Vancouver

Calnan M, Blest-Hopley G, Busch C, Adams M, Ruffell SGD, Piper T, et al. Exploring the Therapeutic Effects of Psychedelics Administered to Military Veterans in Naturalistic Retreat Settings. Brain and Behavior. 2025;15(7). doi:10.1002/brb3.70660

BibTeX
@article{Calnan2025,
  author = {Calnan, Megan and Blest-Hopley, Grace and Busch, Chris and Adams, Milly and Ruffell, Simon G D and Piper, Theodore and Roseman, Leor and Kettner, Hannes and Carhart-Harris, Robin},
  title = {Exploring the Therapeutic Effects of Psychedelics Administered to Military Veterans in Naturalistic Retreat Settings},
  journal = {Brain and Behavior},
  year = {2025},
  volume = {15},
  number = {7},
  doi = {10.1002/brb3.70660}
}
Kostenlos starten →